Down-regulation of MET in hippocampal neurons of Alzheimer's disease brains

Neuropathology

Volumn 34, Issue 3, 2014, Pages 284-290

  Hamasaki, Hideomi ^a   Honda, Hiroyuki ^a   Suzuki, Satoshi O ^a   Hokama, Masaaki ^b   Kiyohara, Yutaka ^a   Nakabeppu, Yusaku ^b   Iwaki, Toru ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; HGF; MET; Neurotrophic factor; Senile plaque

Indexed keywords

SCATTER FACTOR RECEPTOR; BIOLOGICAL MARKER; MET PROTEIN, HUMAN;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BRAIN NERVE CELL; BRAIN TISSUE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; GRANULE CELL; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; AGED; DOWN REGULATION; ENZYMOLOGY; FEMALE; MALE; METABOLISM; MIDDLE AGED; NERVE CELL; PATHOLOGY; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; DOWN-REGULATION; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; NEURONS; PROTO-ONCOGENE PROTEINS C-MET; PYRAMIDAL CELLS;

EID: 84901690981     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/neup.12095     Document Type: Article

References (32)

1. Matsuzaki T, Sasaki K, Hata J etal. Association of Alzheimer disease pathology with abnormal lipid metabolism: the Hisayama study. Neurology 2011; 77: 1068-1075.
2. Matsuzaki T, Sasaki K, Tanizaki Y etal. Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology 2010; 75: 764-770.
3. Hokama M, Oka S, Leon J etal. Altered expression of diabetes-related genes in Alzheimer's disease brains: the Hisayama study. Cereb Cortex 2013. doi: 10.1093/cercor/bht101
4. Sharma GD, Kakazu A, Bazan HE. Protein kinase c alpha and epsilon differentially modulate hepatocyte growth factor-induced epithelial proliferation and migration. Exp Eye Res 2007; 85: 289-297.
5. Maina F, Klein R. Hepatocyte growth factor, a versatile signal for developing neurons. Nat Neurosci 1999; 2: 213-217.
6. Kokuzawa J, Yoshimura S, Kitajima H etal. Hepatocyte growth factor promotes proliferation and neuronal differentiation of neural stem cells from mouse embryos. Mol Cell Neurosci 2003; 24: 190-197.
7. Kolatsi-Joannou M, Moore R, Winyard PJ, Woolf AS. Expression of hepatocyte growth factor/scatter factor and its receptor, MET, suggests roles in human embryonic organogenesis. Pediatr Res 1997; 41: 657-665.
8. Miyazawa T, Matsumoto K, Ohmichi H, Katoh H, Yamashima T, Nakamura T. Protection of hippocampal neurons from ischemia-induced delayed neuronal death by hepatocyte growth factor: a novel neurotrophic factor. J Cereb Blood Flow Metab 1998; 18: 345-348.
9. Nagayama T, Nagayama M, Kohara S etal. Post-ischemic delayed expression of hepatocyte growth factor and c-Met in mouse brain following focal cerebral ischemia. Brain Res 2004; 999: 155-166.
10. Niimura M, Takagi N, Takagi K etal. The protective effect of hepatocyte growth factor against cell death in the hippocampus after transient forebrain ischemia is related to the improvement of apurinic/apyrimidinic endonuclease/redox factor-1 level and inhibition of NADPH oxidase activity. Neurosci Lett 2006; 407: 136-140.
11. Shimamura M, Sato N, Sata M, Wakayama K, Ogihara T, Morishita R. Expression of hepatocyte growth factor and c-Met after spinal cord injury in rats. Brain Res 2007; 1151: 188-194.
12. Kato S, Funakoshi H, Nakamura T etal. Expression of hepatocyte growth factor and c-Met in the anterior horn cells of the spinal cord in the patients with amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS and familial ALS with superoxide dismutase 1 gene mutation. Acta Neuropathol 2003; 106: 112-120.
13. Kitamura K, Fujiyoshi K, Yamane J etal. Human hepatocyte growth factor promotes functional recovery in primates after spinal cord injury. PLoS ONE 2011; 6: e27706.
14. Bai L, Lennon DP, Caplan AI etal. Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat Neurosci 2012; 15: 862-870.
15. Sharma S. Hepatocyte growth factor in synaptic plasticity and Alzheimer's disease. ScientificWorldJournal 2010; 10: 457-461.
16. Date I, Takagi N, Takagi K etal. Hepatocyte growth factor improved learning and memory dysfunction of microsphere-embolized rats. J Neurosci Res 2004; 78: 442-453.
17. Wang TW, Zhang H, Gyetko MR, Parent JM. Hepatocyte growth factor acts as a mitogen and chemoattractant for postnatal subventricular zone-olfactory bulb neurogenesis. Mol Cell Neurosci 2011; 48: 38-50.
18. Ohara T, Doi Y, Ninomiya T etal. Glucose tolerance status and risk of dementia in the community: the Hisayama study. Neurology 2011; 77: 1126-1134.
19. de la Monte SM. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. Curr Alzheimer Res 2012; 9: 35-66.
20. Fafalios A, Ma J, Tan X etal. A hepatocyte growth factor receptor (Met)-insulin receptor hybrid governs hepatic glucose metabolism. Nat Med 2011; 17: 1577-1584.
21. Mirra SS, Heyman A, McKeel D etal. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-486.
22. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006; 112: 389-404.
23. Jung W, Castren E, Odenthal M etal. Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-Met in mammalian brain. J Cell Biol 1994; 126: 485-494.
24. Honda S, Kagoshima M, Wanaka A, Tohyama M, Matsumoto K, Nakamura T. Localization and functional coupling of HGF and c-Met/HGF receptor in rat brain: implication as neurotrophic factor. Brain Res Mol Brain Res 1995; 32: 197-210.
25. Kato T, Funakoshi H, Kadoyama K etal. Hepatocyte growth factor overexpression in the nervous system enhances learning and memory performance in mice. J Neurosci Res 2012; 90: 1743-1755.
26. Yamada T, Tsubouchi H, Daikuhara Y etal. Immunohistochemistry with antibodies to hepatocyte growth factor and its receptor protein (c-Met) in human brain tissues. Brain Res 1994; 637: 308-312.
27. Zhang L, Himi T, Murota S. Induction of hepatocyte growth factor (HGF) in rat microglial cells by prostaglandin E(2). J Neurosci Res 2000; 62: 389-395.
28. Di Renzo MF, Bertolotto A, Olivero M etal. Selective expression of the Met/HGF receptor in human central nervous system microglia. Oncogene 1993; 8: 219-222.
29. Yan H, Rivkees SA. Hepatocyte growth factor stimulates the proliferation and migration of oligodendrocyte precursor cells. J Neurosci Res 2002; 69: 597-606.
30. Zamanian JL, Xu L, Foo LC etal. Genomic analysis of reactive astrogliosis. J Neurosci 2012; 32: 6391-6410.
31. Fenton H, Finch PW, Rubin JS etal. Hepatocyte growth factor (HGF/SF) in Alzheimer's disease. Brain Res 1998; 779: 262-270.
32. Ming GL, Song H. Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron 2011; 70: 687-702.